On-demand posters

Check out the latest data on patient-derived organoids that HUB presented at AACR 2023 

Organoid co-cultures with autologous T cells to assess toxicity and efficacy of bispecific antibodies

presented by Sylvia Boj, Chief Scientific Officer, HUB Organoids

Tumor organoid and T-cell co-culture assay to evaluate CAR T-cell cytotoxicity

presented by Eider Valle Encinas, Scientific Business Development Manager, HUB Organoids

Patient in the lab: Down-scaling patient-derived organoid screening for diagnostic purposes

presented by Sylvia Boj, Chief Scientific Officer, HUB Organoids

Optimization of screening conditions using patient-derived organoids for diagnostic purposes

presented by Carla Verissimo, Head of Department Oncology, HUB Organoids

Autologous organoids and T cell co-cultures as a powerful personalized platform for immunotherapy development

presented by Claudia Beaurivage, Senior Scientist, HUB Organoids

Developing a patient-derived organoid biobank, suitable for large-scale drug screenings

presented by Daniele Mori, Scientist, HUB Organoids